Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Antonio Bernardo Michelino De Laurentiis Filippo Montemurro Antonio Gambardella Antonella Lai Stefania Gori Luca Moscetti |
| Publication date | February 23, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |